Nalaganje...
Imatinib in Chronic Myeloid Leukemia: an Overview
Imatinib was the first signal transduction inhibitor (STI), used in a clinical setting. It prevents a BCR-ABL protein from exerting its role in the oncogenic pathway in chronic myeloid leukemia (CML). Imatinib directly inhibits the constitutive tyrosine kinase activity. Imatinib binds to BCR-ABL kin...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Università Cattolica del Sacro Cuore
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3894842/ https://ncbi.nlm.nih.gov/pubmed/24455116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2014.007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|